Sökresultat - Denis Moro‐Sibilot
- Visas 1 - 20 av 68 resultat
- Gå till nästa sida
-
1
First- and second-line therapy for advanced nonsmall cell lung cancer av Sculier Jp, Denis Moro‐Sibilot
Publicerad 2009Revisão -
2
-
3
-
4
Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer av Arnaud Van Den Broeck, Élisabeth Brambilla, Denis Moro‐Sibilot, Sylvie Lantuéjoul, Christian Brambilla, Béatrice Eymin, Saadi Khochbin, Sylvie Gazzéri
Publicerad 2008Artigo -
5
-
6
-
7
Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study av Anne McLeer‐Florin, Denis Moro‐Sibilot, A. Melis, Dimitri Salameire, Christine Lefebvre, Françoise Ceccaldi, Florence de Fraipont, Élisabeth Brambilla, Sylvie Lantuéjoul
Publicerad 2011Artigo -
8
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours av Sylvie Lantuéjoul, Jean‐Charles Soria, Denis Moro‐Sibilot, Luc Morat, Sylvie Veyrenc, P. Lorimier, Pierre-Yves Brichon, Laure Sabatier, Christian Brambilla, Élisabeth Brambilla
Publicerad 2004Artigo -
9
IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype av J. Cadranel, Élisabeth Quoix, Laurence Baudrin, Pierre Mourlanette, Denis Moro‐Sibilot, Jean‐François Morère, Pierre-Jean Souquet, Jean‐Charles Soria, Franck Morin, B. Milleron
Publicerad 2009Artigo -
10
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer av Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar, Pierre-Jean Souquet, P. Merle, Denis Moro‐Sibilot, M. Pérol, Jiří Zavadil, Christian Brambilla, Magali Olivier, S. Couraud
Publicerad 2015Artigo -
11
Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer av Hélène Nagy-Mignotte, Oxana Shestaeva, Lucile Vignoud, Pascale Guillem, Stéphane Ruckly, Olivier Chabre, L. Sakhri, M. Duruisseaux, Mireille Mousseau, Jean‐François Timsit, Denis Moro‐Sibilot
Publicerad 2014Artigo -
12
<i>MET</i> exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung av Raphaël Saffroy, Vincent Fallet, Nicolas Girard, Julien Mazières, Denis Moro‐Sibilot, Sylvie Lantuéjoul, Isabelle Rouquette, Françoise Thivolet-Béjui, Thibaut Vieira, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez
Publicerad 2017Artigo -
13
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas av Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Isabelle Rouquette, Pierre-Jean Souquet, Clarisse Audigier-Valette, Jean‐Christophe Sabourin, C. Decroisette, L. Sakhri, Élisabeth Brambilla, Anne McLeer‐Florin
Publicerad 2013Artigo -
14
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients av J-L. Pujol, Olivier Molinier, W. Ébert, Daurès Jp, Fabrice Barlési, G Buccheri, M Paesmans, Élisabeth Quoix, Denis Moro‐Sibilot, M Szturmowicz, J-M Bréchot, T. Muley, Jean‐Christophe Grenier
Publicerad 2004Revisão -
15
Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity av Christian Brambilla, Julien Laffaire, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Hélène Mignotte, François Arbib, Anne‐Claire Toffart, Fabien Petel, Pierre Hainaut, Sophie Rousseaux, Saadi Khochbin, Aurélien de Reyniès, Élisabeth Brambilla
Publicerad 2014Artigo -
16
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus av Federico Cappuzzo, Denis Moro‐Sibilot, Oliver Gautschi, Ekaterini Boleti, Enriqueta Felip, Harry J.M. Groen, Paul Germonpré, Peter Meldgaard, Edurne Arriola, N. Steele, J. Fox, Patrick Schnell, Arne Engelsberg, Jürgen Wolf
Publicerad 2014Revisão -
17
Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival av E. Pluquet, J. Cadranel, Anne Legendre, Michelle Beau Faller, Pierre Jean Souquet, Gérard Zalcman, M. Pérol, G. Fraboulet, Gerard Oliveiro, Florence de Fraipont, Élisabeth Quoix, Sylvie Lantuéjoul, B. Milleron, Denis Moro‐Sibilot
Publicerad 2010Artigo -
18
High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets av Vincent Fallet, Raphaël Saffroy, Nicolas Girard, Julien Mazières, Sylvie Lantuéjoul, T. Vieira, Isabelle Rouquette, F. Thivolet-Béjui, Mony Ung, Virginie Poulot, L. Schlick, Denis Moro‐Sibilot, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez
Publicerad 2015Artigo -
19
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics av Léonie Ferrer, Matteo Giaj Levra, Marie Brevet, Martine Antoine, Julien Mazières, Giulio Rossi, Rita Chiari, Virginie Westeel, M. Poudenx, J. Letreut, Radj Gervais, Giorgia Osman, Nicolas Girard, Anne Claire Toffart, Silvia Novello, Denis Moro‐Sibilot
Publicerad 2018Artigo -
20
Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer av Stéphane Vignot, Garrett M. Frampton, Jean‐Charles Soria, Roman Yelensky, Frédéric Commo, Christian Brambilla, Gary A. Palmer, Denis Moro‐Sibilot, Jeffrey S. Ross, Maureen Cronin, Fabrice André, Philip J. Stephens, Vladimir Lazar, Vincent A. Miller, Élisabeth Brambilla
Publicerad 2013Artigo
Sökverktyg:
Relaterade ämnen
Medicine
Internal medicine
Lung cancer
Oncology
Cancer
Chemotherapy
Biology
Cancer research
Genetics
Gene
Pathology
Cisplatin
Surgery
Clinical endpoint
Immunotherapy
Confidence interval
Gastroenterology
Hazard ratio
Malignant pleural effusion
Crizotinib
Epidermal growth factor receptor
Randomized controlled trial
Adenocarcinoma
Nivolumab
Pemetrexed
Bevacizumab
Lung
Atezolizumab
Docetaxel
Environmental health